No Data
The reproductive rehabilitation products have grown, and Mailand's net profit for 2024 has increased by 13.75% year-on-year.
① In 2024, Mylan achieved operating revenue of 0.425 billion yuan, a year-on-year growth of 24.57%; achieved net income attributable to parent company of 0.102 billion yuan, a year-on-year growth of 13.10%; ② Mylan stated that the medical instruments industry in our country is in a rapid development stage, especially in the field of pelvic floor and obstetric and gynecological rehabilitation, where demand continues to grow. This industry has ushered in unprecedented development opportunities.
MacLander: 2024 Annual Report
MacLander: 2024 Annual Report Summary
Melander: First quarter report 2025
2024 Annual Report
Summary of the 2024 Annual Report